GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » American Green Inc (OTCPK:ERBB) » Definitions » FCF Margin %

American Green (American Green) FCF Margin % : -5.38% (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is American Green FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. American Green's Free Cash Flow for the six months ended in Jun. 2023 was $-0.20 Mil. American Green's Revenue for the six months ended in Jun. 2023 was $3.79 Mil. Therefore, American Green's FCF Margin % for the quarter that ended in Jun. 2023 was -5.38%.

As of today, American Green's current FCF Yield % is -9.53%.

The historical rank and industry rank for American Green's FCF Margin % or its related term are showing as below:

ERBB' s FCF Margin % Range Over the Past 10 Years
Min: -300.95   Med: -153.17   Max: -5.38
Current: -5.38


During the past 2 years, the highest FCF Margin % of American Green was -5.38%. The lowest was -300.95%. And the median was -153.17%.

ERBB's FCF Margin % is ranked worse than
62.32% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.2 vs ERBB: -5.38


American Green FCF Margin % Historical Data

The historical data trend for American Green's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Green FCF Margin % Chart

American Green Annual Data
Trend Jun22 Jun23
FCF Margin %
-300.95 -5.38

American Green Semi-Annual Data
Jun22 Jun23
FCF Margin % -300.95 -5.38

Competitive Comparison of American Green's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, American Green's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Green's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, American Green's FCF Margin % distribution charts can be found below:

* The bar in red indicates where American Green's FCF Margin % falls into.



American Green FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

American Green's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-0.204/3.793
=-5.38 %

American Green's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-0.204/3.793
=-5.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Green FCF Margin % Related Terms

Thank you for viewing the detailed overview of American Green's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


American Green (American Green) Business Description

Traded in Other Exchanges
N/A
Address
30 N Gould Street, Suite R, Sheridan, WY, USA, 82801
American Green Inc is a technology company in the medical cannabis industry. It is involved in the business of developing a cultivation facility in Phoenix Arizona for medical marijuana and also owns proprietary dispensing machines and all rights to a line of health supplements.